|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3000 USD | +3.45% |
|
-2.22% | -39.76% |
| 03-19 | Cosmos Health Says It May Use Noncore Assets to Help Fund Future Plans | MT |
| 03-19 | Cosmos Health says Middle East war, recent geopolitical turmoil had negligible impact on operations | RE |
Company Valuation: Cosmos Health Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 48.22 | 18.78 | 14.06 | 10.48 | 10.48 | - |
| Change | - | -61.06% | -25.13% | -25.48% | 0% | - |
| Enterprise Value (EV) | 48.22 | 18.78 | 14.06 | 10.48 | 10.48 | 10.48 |
| Change | - | -61.06% | -25.13% | -25.48% | 0% | 0% |
| P/E ratio | -0.14x | -0.66x | -0.57x | -0.88x | -2.73x | 4.29x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | 0x | -0x |
| Capitalization / Revenue | - | 0.35x | - | 0.16x | 0.11x | 0.08x |
| EV / Revenue | - | 0x | - | 0.16x | 0.11x | 0.08x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -33.16 | -2.15 | -1.17 | -0.34 | -0.11 | 0.07 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 53.38 | - | 64.4 | 98.6 | 130.8 |
| EBITDA | - | -21.24 | - | - | - | - |
| EBIT | - | -21.83 | - | - | - | - |
| Net income | -13.83 | -25.78 | -22.38 | - | - | - |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 4.5600 | 1.4100 | 0.6690 | 0.3000 | 0.3000 | 0.3000 |
| Nbr of stocks (in thousands) | 10,574 | 13,318 | 21,014 | 34,920 | 34,920 | - |
| Announcement Date | 12/04/23 | 05/08/24 | 15/04/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.88x | - | - | - | 10.48M | ||
| 24.58x | 0.26x | 15.93x | 0.35% | 106B | ||
| 26.23x | 0.22x | 14.15x | 0.96% | 50.72B | ||
| 42.96x | 2.9x | 26.95x | 1.47% | 21.93B | ||
| 16.37x | 1.32x | 10.39x | 1.9% | 9.24B | ||
| 11.83x | 0.22x | 5.72x | 2.5% | 8.42B | ||
| 7.72x | 0.1x | 2.92x | 3.9% | 8.34B | ||
| 9.3x | 1.7x | 5.4x | 3.47% | 6.09B | ||
| 25.21x | 1.24x | 15.49x | 2.78% | 5.77B | ||
| 10.16x | 0.14x | 4.83x | 4.16% | 3.91B | ||
| Average | 17.35x | 0.90x | 11.31x | 2.39% | 22.05B | |
| Weighted average by Cap. | 24.66x | 0.61x | 15.00x | 1.1% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- COSM Stock
- Valuation Cosmos Health Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















